Galera Therapeutics Goes Public with 60 Million IPO

Biopharmaceutical firm Galera Therapeutics, which was founded in St. Louis a decade ago, is now a public company traded on Nasdaq.

Galera raised $60 million Wednesday in its initial public stock offering, selling 5 million shares at $12 apiece. The shares surged as high as $13.43 in Thursday morning trading before settling back near the $12 level.